Literature DB >> 19002786

Intracellular distribution of anthracyclines in drug resistant cells.

G Arancia1, A Calcabrini, S Meschini, A Molinari.   

Abstract

The unresponsiveness of multidrug resistant tumor cells to antineoplastic chemotherapy is often associated with reduced cellular drug accumulation accomplished by overexpressed transport molecules. Moreover, intracellular drug distribution in resistant cells appears to be remarkably different when compared to their wild type counterparts. In the present paper, we report observations on the intracellular accumulation and distribution of doxorubicin, an antitumoral agent widely employed in chemotherapy, in sensitive and resistant cultured tumor cells. The inherent fluorescence of doxorubicin allowed us to follow its fate in living cells by laser scanning confocal microscopy. This study included flow cytometric analysis of drug uptake and efflux and analysis of the presence of the well known drug transporter P-glycoprotein. Morphological, immunocytochemical and functional data evidentiated the Golgi apparatus as the preferential intracytoplasmic site of drug accumulation in resistant cells, capable of sequestering doxorubicin away from the nuclear target. Moreover, P-glycoprotein has been found located in the Golgi apparatus in drug induced resistant cells and in intrinsic resistant cells, such as melanoma cells. Thus, this organelle seems to play a pivotal role in the intracellular distribution of doxorubicin.

Entities:  

Year:  1998        PMID: 19002786      PMCID: PMC3449566          DOI: 10.1023/A:1008040117882

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  56 in total

1.  Affinity of adriamycin to phospholipids. A possible explanation for cardiac mitochondrial lesions.

Authors:  M Duarte-Karim; J M Ruysschaert; J Hildebrand
Journal:  Biochem Biophys Res Commun       Date:  1976-07-26       Impact factor: 3.575

2.  Binding of daunomycin to DNA and the inhibition of RNA and DNA synthesis.

Authors:  N S Mizuno; B Zakis; R W Decker
Journal:  Cancer Res       Date:  1975-06       Impact factor: 12.701

3.  Mechanism of multidrug resistance in human tumour cell lines and complete reversion of cellular resistance.

Authors:  M Boiocchi; G Toffoli
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

4.  P-glycoprotein epitope mapping. I. Identification of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi-drug-resistant cells.

Authors:  M Cianfriglia; M C Willingham; M Tombesi; G V Scagliotti; G Frasca; A Chersi
Journal:  Int J Cancer       Date:  1994-01-02       Impact factor: 7.396

5.  Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers.

Authors:  A R Safa; C J Glover; J L Sewell; M B Meyers; J L Biedler; R L Felsted
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

Review 6.  Ultrastructural and spectroscopic methods in the study of anthracycline-membrane interaction.

Authors:  G Arancia; F Bordi; A Calcabrini; M Diociaiuti; A Molinari
Journal:  Pharmacol Res       Date:  1995-11       Impact factor: 7.658

7.  Human P-glycoprotein transports cyclosporin A and FK506.

Authors:  T Saeki; K Ueda; Y Tanigawara; R Hori; T Komano
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

8.  Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines.

Authors:  A Fojo; S Akiyama; M M Gottesman; I Pastan
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

9.  Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on interaction of daunomycin with deoxyribonucleic acid.

Authors:  J B Chaires; N Dattagupta; D M Crothers
Journal:  Biochemistry       Date:  1982-08-17       Impact factor: 3.162

10.  Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: geometry of intercalation of iremycin and daunomycin.

Authors:  H Fritzsche; H Triebel; J B Chaires; N Dattagupta; D M Crothers
Journal:  Biochemistry       Date:  1982-08-17       Impact factor: 3.162

View more
  10 in total

1.  Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles.

Authors:  Ganna V Kalayda; Bart A J Jansen; Peter Wielaard; Hans J Tanke; Jan Reedijk
Journal:  J Biol Inorg Chem       Date:  2005-04-12       Impact factor: 3.358

Review 2.  Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?

Authors:  Wing-Kee Lee; Richard N Kolesnick
Journal:  Cell Signal       Date:  2017-07-04       Impact factor: 4.315

3.  Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part I. Synthesis, cytotoxicity, and cellular studies in A2780 human ovarian carcinoma cells.

Authors:  Bart A J Jansen; Peter Wielaard; Ganna V Kalayda; Maura Ferrari; Chris Molenaar; Hans J Tanke; Jaap Brouwer; Jan Reedijk
Journal:  J Biol Inorg Chem       Date:  2004-04-08       Impact factor: 3.358

4.  Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation.

Authors:  John P Sinek; Sandeep Sanga; Xiaoming Zheng; Hermann B Frieboes; Mauro Ferrari; Vittorio Cristini
Journal:  J Math Biol       Date:  2008-09-10       Impact factor: 2.259

5.  The Goldilocks Window of Personalized Chemotherapy: Getting the Immune Response Just Right.

Authors:  Derek S Park; Mark Robertson-Tessi; Kimberly A Luddy; Philip K Maini; Michael B Bonsall; Robert A Gatenby; Alexander R A Anderson
Journal:  Cancer Res       Date:  2019-08-06       Impact factor: 12.701

6.  Melanoma chemotherapy leads to the selection of ABCB5-expressing cells.

Authors:  Marine Chartrain; Joëlle Riond; Aline Stennevin; Isabelle Vandenberghe; Bruno Gomes; Laurence Lamant; Nicolas Meyer; Jean Edouard Gairin; Nicolas Guilbaud; Jean Philippe Annereau
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

Review 7.  Mechanisms of Drug Resistance in Veterinary Oncology- A Review with an Emphasis on Canine Lymphoma.

Authors:  Maurice Zandvliet; Erik Teske
Journal:  Vet Sci       Date:  2015-08-12

8.  Interactions of Cisplatin and Daunorubicin at the Chromatin Level.

Authors:  Erfaneh Firouzi Niaki; Thibaut Van Acker; László Imre; Péter Nánási; Szabolcs Tarapcsák; Zsolt Bacsó; Frank Vanhaecke; Gábor Szabó
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

9.  Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines.

Authors:  Michela Levi; Roberta Salaroli; Federico Parenti; Raffaella De Maria; Augusta Zannoni; Chiara Bernardini; Cecilia Gola; Antonio Brocco; Asia Marangio; Cinzia Benazzi; Luisa Vera Muscatello; Barbara Brunetti; Monica Forni; Giuseppe Sarli
Journal:  BMC Vet Res       Date:  2021-01-18       Impact factor: 2.741

10.  Marine-derived Fungi Extracts Enhance the Cytotoxic Activity of Doxorubicin in Nonsmall Cell Lung Cancer Cells A459.

Authors:  Bruno Castro-Carvalho; Alice A Ramos; Maria Prata-Sena; Fernanda Malhão; Márcia Moreira; Daniela Gargiulo; Tida Dethoup; Suradet Buttachon; Anake Kijjoa; Eduardo Rocha
Journal:  Pharmacognosy Res       Date:  2017-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.